For both primary CRC and the liver metastases, the probability of a sample being in the MCL1 medium/high group is higher for a sample in the Bcl-xL medium/high group when compared to a sample in the Bcl-xL low/negative group (Fig. 5B). This evidence concerns the gene BCL2L1 and colorectal carcinoma.